Archon Bioscience

Archon Bioscience is a biotech startup developing novel biomolecules using AI. Its core technology involves creating protein "cages" that enhance the effectiveness of antibody treatments, addressing limitations in current drug development. This innovative approach aims to significantly improve the binding and efficacy of antibody-based therapies.


Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $20M

Date: 30-Oct-2024

Investors: Madrona Ventures, DUMAC Inc., Sahsen Ventures, WRF Capital, Pack Ventures, Alexandria Venture Investments, Cornucopian Capital

Markets: Biotech, AI, Drug Development

HQ: Seattle, Washington, United States

Founded: 2023

Website: https://www.archon.bio/

LinkedIn: https://www.linkedin.com/company/archonbio

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/archon-biosciences

Pitchbook: https://pitchbook.com/profiles/company/606448-99


Leave a Comment